Status:

UNKNOWN

Contrast Enhanced Ultrasound Guidance Biopsy for the Diagnosis of Liver Tumors

Lead Sponsor:

Iuliu Hatieganu University of Medicine and Pharmacy

Conditions:

Liver Diseases

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The main purpose of this study is to compare contrast-enhanced ultrasound guided liver biopsy (CEUS-LB) with conventional ultrasound guided liver biopsy (US-LB) in the diagnosis of liver tumors develo...

Detailed Description

A prospective parallel group clinical trial will be performed. The study protocol was implemented in our Institute starting January 2011 ending January 1 2020. During this period, all patients with a ...

Eligibility Criteria

Inclusion

  • presence of cirrhosis or other chronic liver disease (according to a liver stiffness evaluated by transient elastography higher than 10 kilopascals)
  • Child-Pugh score no higher than B7 and absence of perihepatic ascites
  • platelet count \> 50.000 per mm3
  • international normalized ratio \< 1.6

Exclusion

  • tumors located tin sonography blind areas
  • refuse to sign the informed consent

Key Trial Info

Start Date :

January 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2020

Estimated Enrollment :

138 Patients enrolled

Trial Details

Trial ID

NCT03811431

Start Date

January 1 2011

End Date

January 1 2020

Last Update

January 22 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Regional Institute of Gastroenterology and Hepatology "Octavian Fodor"

Cluj-Napoca, Please Enter the State Or Province, Romania, 400126